173 related articles for article (PubMed ID: 38365418)
21. Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.
Lo AC; Faye B; Ba el-H; Cisse B; Tine R; Abiola A; Ndiaye M; Ndiaye JL; Ndiaye D; Sokhna C; Gomis JF; Dieng Y; Faye O; Ndir O; Milligan P; Cairns M; Hallett R; Sutherland C; Gaye O
Malar J; 2013 Apr; 12():137. PubMed ID: 23617576
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic considerations in seasonal malaria chemoprevention.
Chotsiri P; White NJ; Tarning J
Trends Parasitol; 2022 Aug; 38(8):673-682. PubMed ID: 35688778
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries.
Cairns M; Ceesay SJ; Sagara I; Zongo I; Kessely H; Gamougam K; Diallo A; Ogboi JS; Moroso D; Van Hulle S; Eloike T; Snell P; Scott S; Merle C; Bojang K; Ouedraogo JB; Dicko A; Ndiaye JL; Milligan P
PLoS Med; 2021 Sep; 18(9):e1003727. PubMed ID: 34495978
[TBL] [Abstract][Full Text] [Related]
24. Evidence that seasonal malaria chemoprevention with SPAQ influences blood and pre-erythrocytic stage antibody responses of Plasmodium falciparum infections in Niger.
Mahaman Moustapha L; Adamou R; Ibrahim ML; Abdoulaye Louis Padounou M; Diallo A; Courtin D; Testa J; Ndiaye JLA
Malar J; 2021 Jan; 20(1):1. PubMed ID: 33386070
[TBL] [Abstract][Full Text] [Related]
25. Seasonal malaria chemoprevention: successes and missed opportunities.
Coldiron ME; Von Seidlein L; Grais RF
Malar J; 2017 Nov; 16(1):481. PubMed ID: 29183327
[TBL] [Abstract][Full Text] [Related]
26. Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso.
Zongo I; Milligan P; Compaore YD; Some AF; Greenwood B; Tarning J; Rosenthal PJ; Sutherland C; Nosten F; Ouedraogo JB
Antimicrob Agents Chemother; 2015 Aug; 59(8):4387-96. PubMed ID: 25918149
[TBL] [Abstract][Full Text] [Related]
27. Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso.
Koita K; Bognini JD; Agboraw E; Dembélé M; Yabré S; Bihoun B; Coulibaly O; Niangaly H; N'Takpé JB; Lesosky M; Scaramuzzi D; Worrall E; Hill J; Briand V; Tinto H; Kayentao K
BMC Public Health; 2024 Jan; 24(1):43. PubMed ID: 38166711
[TBL] [Abstract][Full Text] [Related]
28. Seasonal Malaria Chemoprevention Therapy in Children Up To 9 Years of Age: Protocol for a Cluster-Randomized Trial Study.
Toure M; Shaffer JG; Sanogo D; Keita S; Keita M; Kane F; Traore B; Dabitao D; Kone A; Doumbia CO; Keating J; Yukich J; Hansson HH; Barry AE; Diakité M; Alifrangis M; Doumbia S
JMIR Res Protoc; 2024 Jan; 13():e51660. PubMed ID: 38252481
[TBL] [Abstract][Full Text] [Related]
29. A hybrid effectiveness-implementation study protocol to assess the effectiveness and chemoprevention efficacy of implementing seasonal malaria chemoprevention in five districts in Karamoja region, Uganda.
Kajubi R; Ainsworth J; Baker K; Richardson S; Bonnington C; Rassi C; Achan J; Magumba G; Rubahika D; Nabakooza J; Tibenderana J; Nuwa A; Opigo J
Gates Open Res; 2023; 7():14. PubMed ID: 38196920
[TBL] [Abstract][Full Text] [Related]
30. A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda.
Nuwa A; Baker K; Bonnington C; Odongo M; Kyagulanyi T; Bwanika JB; Richardson S; Nabakooza J; Achan J; Kajubi R; Odong DS; Nakirunda M; Magumba G; Beinomugisha G; Marasciulo-Rice M; Abio H; Rassi C; Rutazaana D; Rubahika D; Tibenderana J; Opigo J
Malar J; 2023 Feb; 22(1):63. PubMed ID: 36814301
[TBL] [Abstract][Full Text] [Related]
31. Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial.
Barry A; Issiaka D; Traore T; Mahamar A; Diarra B; Sagara I; Kone D; Doumbo OK; Duffy P; Fried M; Dicko A
PLoS One; 2018; 13(3):e0193296. PubMed ID: 29505578
[TBL] [Abstract][Full Text] [Related]
32. Large-scale delivery of seasonal malaria chemoprevention to children under 10 in Senegal: an economic analysis.
Pitt C; Ndiaye M; Conteh L; Sy O; Hadj Ba E; Cissé B; Gomis JF; Gaye O; Ndiaye JL; Milligan PJ
Health Policy Plan; 2017 Nov; 32(9):1256-1266. PubMed ID: 28981665
[TBL] [Abstract][Full Text] [Related]
33. Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01
Chandramohan D; Dicko A; Zongo I; Sagara I; Cairns M; Kuepfer I; Diarra M; Tapily A; Issiaka D; Sanogo K; Mahamar A; Sompougdou F; Yerbanga S; Thera I; Milligan P; Tinto H; Ofori-Anyinam O; Ouedraogo JB; Greenwood B
BMJ Open; 2020 Sep; 10(9):e035433. PubMed ID: 32933955
[TBL] [Abstract][Full Text] [Related]
34. Impact of seasonal malaria chemoprevention based on the number of medicines doses received on malaria burden among children aged 3-59 months in Nigeria: A propensity score-matched analysis.
Huang S; Baker K; Ibinaiye T; Oresanya O; Nnaji C; Richardson S
Trop Med Int Health; 2024 Jun; ():. PubMed ID: 38842452
[TBL] [Abstract][Full Text] [Related]
35. Investigating selected host and parasite factors potentially impacting upon seasonal malaria chemoprevention in Bama, Burkina Faso.
Somé FA; Bazié T; Ehrlich HY; Goodwin J; Lehane A; Neya C; Zachari K; Wade M; Ouattara JM; Foy BD; Dabiré RK; Parikh S; Ouédraogo JB
Malar J; 2020 Jul; 19(1):238. PubMed ID: 32631416
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness and Community Acceptance of Extending Seasonal Malaria Chemoprevention to Children 5 to 14 Years of Age in Dangassa, Mali.
Konaté D; Diawara SI; Keita B; Sogoba N; Fayiçal M; Guindo A; Thiam S; Traoré SF; Shaffer JG; Doumbia S; Diakité M
Am J Trop Med Hyg; 2021 Nov; 106(2):648-654. PubMed ID: 34781256
[TBL] [Abstract][Full Text] [Related]
37. The Duration of Protection from Azithromycin Against Malaria, Acute Respiratory, Gastrointestinal, and Skin Infections When Given Alongside Seasonal Malaria Chemoprevention: Secondary Analyses of Data from a Clinical Trial in Houndé, Burkina Faso, and Bougouni, Mali.
Phiri MD; Cairns M; Zongo I; Nikiema F; Diarra M; Yerbanga RS; Barry A; Tapily A; Coumare S; Thera I; Kuepfer I; Milligan P; Tinto H; Dicko A; Ouédraogo JB; Greenwood B; Chandramohan D; Sagara I
Clin Infect Dis; 2021 Oct; 73(7):e2379-e2386. PubMed ID: 33417683
[TBL] [Abstract][Full Text] [Related]
38. Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso.
Traore A; Donovan L; Sawadogo B; Ward C; Smith H; Rassi C; Counihan H; Johansson J; Richardson S; Savadogo JR; Baker K
BMC Public Health; 2022 Mar; 22(1):442. PubMed ID: 35247990
[TBL] [Abstract][Full Text] [Related]
39. Modeled Impact of Seasonal Malaria Chemoprevention on District-Level Suspected and Confirmed Malaria Cases in Chad Based on Routine Clinical Data (2013-2018).
Richardson S; Moukenet A; Diar MSI; de Cola MA; Rassi C; Counihan H; Roca-Feltrer A
Am J Trop Med Hyg; 2021 Oct; 105(6):1712-1721. PubMed ID: 34662864
[TBL] [Abstract][Full Text] [Related]
40. Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad, and Togo.
Ibinaiye T; Oresanya O; Oguoma C; Aidenagbon A; Ogunmola O; Rassi C; Richardson S
Malar J; 2023 May; 22(1):148. PubMed ID: 37147685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
